GlassScriptPhysician profile
Arvind Kapila
NPI 1730157553
$15,151.51
in general payments reported to CMS, 2019-2025
14 companies · $3,957 in 2025
The $3,957 reported for 2025 was more than what 90% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,862 · 2020: $1,355 · 2021: $1,839 · 2022: $3,946 · 2023: $540 · 2024: $652 · 2025: $3,957.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,105 · Consulting Fee: $1,840 · Travel and Lodging: $1,205.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,104.77 |
| Consulting Fee | $1,840.00 |
| Travel and Lodging | $1,204.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $6,275.48 | 2019-2025 | Triclip, Mitraclip, Epic |
| Medtronic, INC. | $4,241.89 | 2021-2024 | Corevalve Evolut R |
| Edwards Lifesciences Corporation | $3,685.74 | 2019-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv), Pascal |
| Medtronic Vascular, INC. | $285.48 | 2019-2020 | |
| Boston Scientific Corporation | $200.55 | 2020-2025 | Watchman Access System, Versacross Steerable Access Solution |
| Abiomed | $158.19 | 2023-2025 | Impella |
| Cvrx, INC. | $136.62 | 2019 | |
| Biosense Webster, INC. | $39.26 | 2024 | Carto 3 |
| Cordis US Corp. | $24.83 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $23.97 | 2024 | Lifevest |
| Davol INC. | $22.13 | 2025 | Arista |
| Covidien LP | $21.42 | 2020 | |
| Conmed Corporation | $19.35 | 2025 | Airseal |
| Masimo Corporation | $16.60 | 2023 | Sedline |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arvind Kapila listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.